Hpv Decontamination Systems Market: To Reach Us$ 220.05 Mn By 2024

HPV decontamination systems rely on microcondensation for the total elimination of pathogens from an inert environment. HPV is used in hospitals globally, primarily for the complete disinfection of rooms that are used for patient care and also to reduce the risk of spreading to the subsequent room. The growing prevalence of healthcare-associated infections (HAIs) has led to increasing use of HPV decontamination systems in hospitals and facilities worldwide. International regulatory bodies’ emphasis on sterile testing and aseptic processing is one of the major drivers of the market’s growth. Cost effectiveness with minimum downtime to business activities and operations of HPV decontaminations has also bolstered the growth of the HPV decontamination systems market.

Report Detail: https://www.transparencymarketresearch.com/hpv-decontamination-systems-market.html

The demand for the decontamination of laboratory-scale incubators among customers on a regular basis due to various research changes or accidental spillage, has led to increasing adoption of HPV decontamination systems in this segment. The isolators application segment is anticipated to grow the fastest, with an expected CAGR of 7.9% during the forecast period due to its use of barrier technology to minimize the risks of contamination. In 2015, the incubators application segment of the global HPV decontamination systems market generated revenues of US$ 39.81 Mn, which is approximately 30% of the overall HPV decontamination systems market.

Request PDF Brochure: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=10163

The growing rates healthcare-acquired infections (HAIs) makes hospital environments highly susceptible to pathogens. These pathogens pose a significant risk of infection for room occupants. Routine cleaning reduces the risk of microbiological infection in a patient’s room. Therefore, increasing demand for prevention of viral infections is supporting the HPV decontamination systems market’s growth. International regulatory bodies emphasize sterility tests and aseptic processing, which is further acting as a major driver for the growth of the market for HPV decontamination systems. Regulatory bodies force manufacturers to introduce sterility test procedures to demonstrate that the product is manufactured under sterile conditions. HPV decontamination systems are cost effective, with minimum downtime to business operations, which is also a supporting factor for this market’s growth. Inefficient decontamination of open-plan multi-bed units is one of the major restraints to the growth of the HPV decontamination systems market. The growth of antibiotic resistance will offers substantial growth opportunities for the HPV decontamination systems market in the coming years. The issue of antibiotic resistance was highlighted in 2014 by organizations such as the World Health Organization (WHO). Pathogens such as MRSA and Clostridium difficile contribute to a significant proportion of HAIs, and require various classes of antibiotics for their treatment. However, in recent years, highly antibiotic-resistant and untreatable infections are increasing fatality rates in hospitals. Also, the imposition of stringent regulations and compliance in the life sciences and healthcare sectors and decontamination activities in spacecraft and in the airlines industry are also major growth opportunities for the HPV decontamination systems market. The global HPV decontamination systems market generated revenues of US$ 122.75 Mn in 2015 and is projected to expand at a CAGR of 6.7% during the forecast period (2016 – 2024) to reach US$ 220.05 Mn by 2024.

On the basis of applications, the HPV decontamination systems market is segmented into incubators, autoclave/cage washers, isolators, and rooms/facilities. Incubators are widely used in laboratory environments and for research applications such as cell culturing, neuroscience, tissue engineering, in-vitro fertilization, cancer research, stem cell research, embryonic stem cell research, and other research and mammalian cells cultivation. This generates significant demand for HPV decontamination systems solutions for these applications. Isolators have become a major approach for sterility testing and hydrogen peroxide vapor as become the predominant sterilant. Isolators use a barrier to minimize the risk of contamination, making them the fastest-growing application segment in the market.

Report TOC: https://www.transparencymarketresearch.com/report-toc/10163

About TMR

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Contact TMR

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email:sales@transparencymarketresearch.com
Website:http://www.transparencymarketresearch.com

This release was published on openPR.